The aim of our study was to evaluate the expression pattern of HER2 overexpression in patients with upper tract urothelial carcinoma (UTUC) and to evaluate its association with clinical outcomes
none6noBackground: HER2 is a potential target of therapy in urothelial cancer (UC). Pathological cas...
Several (pre-) clinical trials are currently investigating the benefit of HER2-targeted therapy in u...
The generation of urothelial carcinoma is caused by the accumulation of various molecular changes, a...
AbstractObjectiveSeveral studies have explored the prognostic values of HER2 expression in upper tra...
Objective: Several studies have explored the prognostic values of HER2 expression in upper tract uro...
Background: The worldwide distribution of bladder cancer varies, conforming to differences in enviro...
Aim. HER2 overexpression has been reported in a minority of urothelial carcinomas, but little is kno...
Background: The frequency of over-expression of human epidermal growth factor receptor-2 (HER-2) in ...
AIM: To assess HER-2 and p-AKT expression in upper urinary tract urothelial carcinoma (UTUC) in orde...
We evaluated primary tumors from two cohorts, Spain (N = 111) and Greece (N = 102), for patients who...
The generation of urothelial carcinoma is caused by the accumulation of various molecular changes, a...
We analyzed a cohort of 599 cases of urothelial carcinoma for EGFR, ERBB2, and ERBB3 gene expression...
AbstractThis study assessed the human epidermal growth factor receptor-2 (HER2) protein expression i...
carcinomas (UCCs) and 42 paired lymph node metastases to determine frequency of HER2 overexpression,...
Several (pre-) clinical trials are currently investigating the benefit of HER2-targeted therapy in u...
none6noBackground: HER2 is a potential target of therapy in urothelial cancer (UC). Pathological cas...
Several (pre-) clinical trials are currently investigating the benefit of HER2-targeted therapy in u...
The generation of urothelial carcinoma is caused by the accumulation of various molecular changes, a...
AbstractObjectiveSeveral studies have explored the prognostic values of HER2 expression in upper tra...
Objective: Several studies have explored the prognostic values of HER2 expression in upper tract uro...
Background: The worldwide distribution of bladder cancer varies, conforming to differences in enviro...
Aim. HER2 overexpression has been reported in a minority of urothelial carcinomas, but little is kno...
Background: The frequency of over-expression of human epidermal growth factor receptor-2 (HER-2) in ...
AIM: To assess HER-2 and p-AKT expression in upper urinary tract urothelial carcinoma (UTUC) in orde...
We evaluated primary tumors from two cohorts, Spain (N = 111) and Greece (N = 102), for patients who...
The generation of urothelial carcinoma is caused by the accumulation of various molecular changes, a...
We analyzed a cohort of 599 cases of urothelial carcinoma for EGFR, ERBB2, and ERBB3 gene expression...
AbstractThis study assessed the human epidermal growth factor receptor-2 (HER2) protein expression i...
carcinomas (UCCs) and 42 paired lymph node metastases to determine frequency of HER2 overexpression,...
Several (pre-) clinical trials are currently investigating the benefit of HER2-targeted therapy in u...
none6noBackground: HER2 is a potential target of therapy in urothelial cancer (UC). Pathological cas...
Several (pre-) clinical trials are currently investigating the benefit of HER2-targeted therapy in u...
The generation of urothelial carcinoma is caused by the accumulation of various molecular changes, a...